This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Research article
Clinical course, biomarkers, management and outcomes of patients hospitalised due to COVID-19 in Colombia
Nancy Yomayusa
Keralty
Corresponding Author
ORCiD: https://orcid.org/0000-0003-2886-8146
License:
This work is licensed under a CC BY 4.0 License. Read Full License
Background: Coronavirus disease (COVID-19) represents an unprecedented challenge for both people and health systems. Latin America is the current epicentre of the pandemic; however, there is little published clinical information on the clinical characteristics and outcomes.
Objective: To analyse the clinic characteristics, risk factors and evolution of the first cohort of hospitalised patients with confirmed infection by COVID-19 in 5 Colombian institutions.
Methods: In the present retrospective observational study, information was acquired from consecutive hospitalized patients with a diagnosis of COVID-19 confirmed by real-time reverse transcriptase polymerase chain reaction (RT-PCR) from March 01 to May 30, 2020 in Colombia.
Results: A total of 44 patients were included. The median age was 62 years, and 65.9% of the patients were male. A total of 69.8% of the patients were overweight or obese, and 13.6% of the patients had high blood pressure and diabetes. The presence of systemic symptoms and cough were the most common. Ground-glass opacity was frequent finding upon chest imaging. The 30-day mortality rate was 47.7% with a median of 11 days. The composite outcome (critical care requirement, mechanical ventilation and death) occurred in 36.4% of the patients. The biomarkers associated with mortality risk included troponin higher than 14 ng/L (RR: 5.25; 95% CI 1.37-20.1, p = 0.004) and D-dimer higher than 1000 ng/ml (RR: 3.0; 95% CI 1.4-6.3, p = 0.008). Cardiovascular complications, acute respiratory distress syndrome (ARDS) and acute kidney injury were the most frequent comorbidities in patients with severe pneumonia.
Conclusion: The clinical course of SARS-CoV-2 infection diagnosis confirmed by RT-PCR in Colombian patients admitted to a high-complexity hospital was similar to that reported in the literature; however, the population was characterised by a more advanced stage of the infection.
Keywords
Coronavirus disease 2019, SARS-CoV-2, risk factor, mortality, COVID-19
Figure 1
Figure 2
Leonardo Medina Ospina MD
commented on 27 August, 2020
Excellent article and contribution to local literature. I am struck by the number of hypertensive patients. Would it be possible to know what antihypertensive drugs they were taking?
Monica Osorio
commented on 27 August, 2020
A very interesting and necessary article for understanding COVID.
María Gómez
commented on 28 August, 2020
Excellent article, more publications about Covid pandemic in South America are needed.
Rocio Fernandez Posada
commented on 28 August, 2020
Great characterization of the Latin American population in the SARS-CoV-2 pandemic, it will definitely help as a baseline for further research
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
History
CURRENT STATUS: Posted
Version 1
Posted 26 Aug, 2020
Community comments: 4
Metrics
Comments: 4
PDF Downloads: ...
HTML Views: ...
Learn more about our company.
This is a preprint. It has not completed peer review.
Research article
Clinical course, biomarkers, management and outcomes of patients hospitalised due to COVID-19 in Colombia
Nancy Yomayusa
Keralty
Corresponding Author
ORCiD: https://orcid.org/0000-0003-2886-8146
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
History
CURRENT STATUS: Posted
Version 1
Posted 26 Aug, 2020
Community comments: 4
Metrics
Comments: 4
PDF Downloads: ...
HTML Views: ...
License:
This work is licensed under a CC BY 4.0 License. Read Full License
Background: Coronavirus disease (COVID-19) represents an unprecedented challenge for both people and health systems. Latin America is the current epicentre of the pandemic; however, there is little published clinical information on the clinical characteristics and outcomes.
Objective: To analyse the clinic characteristics, risk factors and evolution of the first cohort of hospitalised patients with confirmed infection by COVID-19 in 5 Colombian institutions.
Methods: In the present retrospective observational study, information was acquired from consecutive hospitalized patients with a diagnosis of COVID-19 confirmed by real-time reverse transcriptase polymerase chain reaction (RT-PCR) from March 01 to May 30, 2020 in Colombia.
Results: A total of 44 patients were included. The median age was 62 years, and 65.9% of the patients were male. A total of 69.8% of the patients were overweight or obese, and 13.6% of the patients had high blood pressure and diabetes. The presence of systemic symptoms and cough were the most common. Ground-glass opacity was frequent finding upon chest imaging. The 30-day mortality rate was 47.7% with a median of 11 days. The composite outcome (critical care requirement, mechanical ventilation and death) occurred in 36.4% of the patients. The biomarkers associated with mortality risk included troponin higher than 14 ng/L (RR: 5.25; 95% CI 1.37-20.1, p = 0.004) and D-dimer higher than 1000 ng/ml (RR: 3.0; 95% CI 1.4-6.3, p = 0.008). Cardiovascular complications, acute respiratory distress syndrome (ARDS) and acute kidney injury were the most frequent comorbidities in patients with severe pneumonia.
Conclusion: The clinical course of SARS-CoV-2 infection diagnosis confirmed by RT-PCR in Colombian patients admitted to a high-complexity hospital was similar to that reported in the literature; however, the population was characterised by a more advanced stage of the infection.
Figure 1
Figure 2
Leonardo Medina Ospina MD
commented on 27 August, 2020
Excellent article and contribution to local literature. I am struck by the number of hypertensive patients. Would it be possible to know what antihypertensive drugs they were taking?
Monica Osorio
commented on 27 August, 2020
A very interesting and necessary article for understanding COVID.
María Gómez
commented on 28 August, 2020
Excellent article, more publications about Covid pandemic in South America are needed.
Rocio Fernandez Posada
commented on 28 August, 2020
Great characterization of the Latin American population in the SARS-CoV-2 pandemic, it will definitely help as a baseline for further research